A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
A phase 2 trial of PF-08634404, Carboplatin, Paclitaxel / nab-paclitaxel in endometrial cancer and ovarian cancer, run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., now recruiting.
Overview
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients is a phase 2 interventional study registered as NCT06522828 by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., with 80 participants planned, started 2024-10-10 and due to reach its primary completion in 2025-08. Interventions recorded: SSGJ-707, carboplatin, paclitaxel. Conditions listed: Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ov
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialA Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Shares Paclitaxel / nab-paclitaxel, Endometrial cancer, Carboplatin.
- TrialStudy to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitax
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialA Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
- TrialStudy of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialOregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialOregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialPhase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.